Health Risk Assessment

Heart Attack & Stroke Risk Assessment

Atherosclerotic Cardiovascular diseases (ASCVDs) are a group of disorders of heart and blood vessels, including coronary artery disease and cerebrovascular disease. They lead to heart attack and strokes. ASCVD is one of the main causes of death worldwide, accounting up to 31% of deaths worldwide in 2015 (1).

Based on recommendations of American College of Cardiology & American Heart Association (ACC/AHA), calculating the 10-year risk for cardiovascular disease using traditional risk factors is recommended every 4-6 years in patients 20-79 years old who are free from cardiovascular disease (2).

At ISMI, using a combination of patient characteristics and blood tests, we help you determine whether you are at high risk for cardiovascular disease such as heart attack or stroke. This will be followed by patient-specific recommendations and imaging surveillance if you are either at risk for or highly concerned about heart attack or stroke. Advanced imaging techniques are able to detect cardiovascular disease much earlier than functional tests such as echocardiography, ECG or treadmill tests.

Please note that these assessments do NOT replace a clinical consultation with a physician, including your family doctor or specialist physician. Any decision on further measures remains an individual choice based upon a physician-patient consultation and shared decision making between the patient and the treating physician. At ISMI, we remain dedicated to “Each Patient All the Way”, and will assist you in connecting with and being cared for by one of our trusted expert physicians.

You do not need a referral for ISMI’s Risk Assessment Services. Simply contact us or book an appointment.

Lung cancer is the most common cause of cancer-related deaths and the most commonly diagnosed cancer among Canadians – an estimated 26,600 Canadians were diagnosed and 20,900 died from lung cancer in 2015. In Canada, the incidence of lung cancer is currently higher in men than women (although this gap is beginning to narrow) and more than 85% of cases are related to smoking tobacco. Approximately 44% of Canadians (12.6 million) are current or former smokers (1).

At ISMI we help you determine whether you are at risk for lung cancer, followed by a discussion on advanced medical imaging options if you are at risk for or highly concerned about lung cancer.

The average woman has a 12% risk of developing breast cancer in her lifetime. For some women, however, this risk can increase to 85%. “For these women, individualized risk assessment, annual surveillance, and risk reducing strategies can markedly decrease the risk of being diagnosed with breast cancer (1).”

At ISMI, we offer you individualized risk assessment followed by patient-specific recommendations and imaging surveillance if you are either at high-risk for or highly concerned about breast cancer. 

Prostate cancer is the most common cancer among Canadian men (excluding non-melanoma skin cancers). It is the third leading cause of death from cancer in men in Canada (1). Prostate cancer usually grows very slowly (low-grade) and may never cause any symptoms. Many men with prostate cancer will die of other causes rather than from prostate cancer. However, some men will have aggressive (high-grade) prostate cancer that grows rapidly and can spread outside the prostate gland if untreated (2). At ISMI, using a combination of patient characteristics and blood tests, we help you estimate your risk of low-grade (Gleason grade < 7) versus high-grade prostate cancer, followed by a discussion on advanced medical imaging options if you are at risk for or highly concerned about prostate cancer.

Fatty liver disease has been called the silent epidemic. It is a growing condition that affects 20% of Canadians, including children and young adults. Untreated, it can lead to liver failure and liver cancer.

Fatty liver disease usually has no signs or symptoms. Liver enzymes are normal in a large percentage of patients with fatty liver disease (1, 2). Silent, indeed.

At ISMI we help you determine whether you are at high risk to have fatty liver, followed by a discussion on advanced medical imaging options if you are at risk for or highly concerned about fatty liver disease.